227 related articles for article (PubMed ID: 35260172)
1. An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile.
De Angelis ML; Francescangeli F; Nicolazzo C; Signore M; Giuliani A; Colace L; Boe A; Magri V; Baiocchi M; Ciardi A; Scarola F; Spada M; La Torre F; Gazzaniga P; Biffoni M; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2022 Mar; 41(1):86. PubMed ID: 35260172
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.
Schölch S; García SA; Iwata N; Niemietz T; Betzler AM; Nanduri LK; Bork U; Kahlert C; Thepkaysone ML; Swiersy A; Büchler MW; Reissfelder C; Weitz J; Rahbari NN
Oncotarget; 2016 May; 7(19):27232-42. PubMed ID: 27029058
[TBL] [Abstract][Full Text] [Related]
4. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
6. An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer.
De Angelis ML; Francescangeli F; Nicolazzo C; Xhelili E; La Torre F; Colace L; Bruselles A; Macchia D; Vitale S; Gazzaniga P; Baiocchi M; Zeuner A
Front Oncol; 2022; 12():869485. PubMed ID: 35837106
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
Chen J; Cao SW; Cai Z; Zheng L; Wang Q
Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
9. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
Chang S; Sun G; Zhang D; Li Q; Qian H
Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers in circulating tumour cells from metastatic colorectal cancer patients.
Gazzaniga P; Gradilone A; Petracca A; Nicolazzo C; Raimondi C; Iacovelli R; Naso G; Cortesi E
J Cell Mol Med; 2010 Aug; 14(8):2073-7. PubMed ID: 20597995
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
[TBL] [Abstract][Full Text] [Related]
14. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
15. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer.
Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ
J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024
[TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
Kallergi G; Papadaki MA; Politaki E; Mavroudis D; Georgoulias V; Agelaki S
Breast Cancer Res; 2011 Jun; 13(3):R59. PubMed ID: 21663619
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.
Papadaki MA; Kallergi G; Zafeiriou Z; Manouras L; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
BMC Cancer; 2014 Sep; 14():651. PubMed ID: 25182808
[TBL] [Abstract][Full Text] [Related]
18. Fluid Shear Stress Induces EMT of Circulating Tumor Cells via JNK Signaling in Favor of Their Survival during Hematogenous Dissemination.
Xin Y; Li K; Yang M; Tan Y
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143160
[TBL] [Abstract][Full Text] [Related]
19. Biology and significance of circulating and disseminated tumour cells in colorectal cancer.
Steinert G; Schölch S; Koch M; Weitz J
Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614
[TBL] [Abstract][Full Text] [Related]
20. Involvement of immune system and Epithelial-Mesenchymal-Transition in increased invasiveness of clustered circulatory tumor cells in breast cancer.
Khoshbakht S; Azimzadeh Jamalkandi S; Masudi-Nejad A
BMC Med Genomics; 2021 Nov; 14(1):273. PubMed ID: 34801010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
